Shanghai Yingrui Biopharma Co.,Ltd.
Home
About Us
ABOUT US
Corporate Culture
Products
APIs & Intermediates
PEG Derivatives
The others
Services
News
Company News
Industry Trends
Contact Us
NEWS CENTER
Chinese innovative drugs enter the era of billions of dollars in scale development by going global
China's innovative drugs are accelerating their overseas expansion and have entered an era of scale development worth billions of US dollars.
2026-11-06
2026
11-06
Heavy class 1 innovative drug approved for market in China
Stroke is a major public health challenge in China, with high incidence rate, high disability rate, high recurrence rate and other characteristics.
2026-10-28
10-28
Intensive progress in insomnia drug research and development by 2026
In recent years, sleep health issues have received increasing market attention.
2026-10-08
10-08
The first order of a new round of repurchase for domestic pharmaceutical leaders has landed
Recently, Hengrui Pharmaceutical disclosed the "Announcement on the First Repurchase of Company's A-shares", announcing the repurchase of 335000 A-shares through centralized bidding trading on the same day, at a cost of 14.5036 million yuan (excluding transaction costs).
2026-09-23
09-23
Intensive landing of domestic innovative gout drugs
With the continuous improvement of living standards, the incidence rate of gout also rises, and presents a younger trend.
2026-09-09
09-09
The sentiment in the pharmaceutical sector is heating up, with pharmaceutical companies recording 6 daily limit ups within 8 trading days
The sentiment in the pharmaceutical sector is heating up.
2026-08-24
08-24
Global biotech financing is experiencing a surge in popularity
Looking back at July 2026, the global biotechnology industry ushered in an intensive financing boom, and the industry's innovative value continued to be recognized by the capital market.
2026-08-10
08-10
Haisco 2026 continues to make innovative breakthroughs, with new progress in the oncology pipeline!
HSK42360-Na is a new chemical drug of Class 1 independently developed by Hisco.
2026-07-22
07-22
The performance of domestic innovative drugs is accelerating
At present, the domestic pharmaceutical innovation field is showing a strong development momentum.
2026-07-09
07-09
Capital will flock to the brain-computer interface field
According to data, the domestic brain-computer field completed 26 rounds of financing with a total scale of 1.778 billion yuan in 2025.
2026-06-25
06-25